- Born:
- January 1, 1950, Tel Aviv, Israel (age 76)
- Subjects Of Study:
- Alzheimer disease
- brain
- macrophage
- nerve
- neuritic plaque
Michal Schwartz
-
Who is Michal Schwartz?
Michal Schwartz (born in Tel Aviv, Israel, January 1, 1950) is an Israeli neuroimmunologist known for her groundbreaking research on the relationship between the immune system and the brain, and for challenging the idea that immunity should be suppressed in chronic neurodegenerative diseases. She earned a doctorate in immunology from the Weizmann Institute of Science in Rehovot, Israel, in 1977 and became a full professor there in 1998.
Schwartz discovered that T cells and macrophages are required for spinal cord repair. Later, she developed the concept of protective autoimmunity, where adaptive immune cells support brain function and help repair damaged neural tissue, maintaining brain plasticity. Her work also explored using immunotherapies to treat neurodegenerative diseases, such as using PD-1 blockers to treat Alzheimer's disease.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is a neuroimmunologist?
Immunology is the study of the body’s defense mechanisms against foreign substances, while neuroimmunology specifically investigates the relationship between the nervous and immune systems.
Michal Schwartz (born in Tel Aviv, Israel, on January 1, 1950) is an Israeli neuroimmunologist known for her groundbreaking research that challenged the idea that immunity should be suppressed in chronic neurodegenerative diseases like Alzheimer's. Her work demonstrated that immune cells are required for spinal cord repair and that the immune system supports brain function and plasticity. She has also investigated immunotherapies for neurodegenerative diseases.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are Michal Schwartz’s main research areas?
Michal Schwartz is an Israeli neuroimmunologist known for her groundbreaking research on the relationship between the brain and the immune system. Her work challenged the idea that the brain is immune-privileged and that immunity should be suppressed in chronic neurodegenerative diseases.
Schwartz's main research areas include:
* The role of macrophages and T cells in spinal cord repair
* Protective autoimmunity, where adaptive immune cells support brain function and repair damaged neural tissue
* The use of immunotherapies, such as PD-1 blockers, to treat neurodegenerative diseases like Alzheimer's
* The link between neurodevelopmental disorders and disruptions in the maternal immune system during pregnancy1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How has Michal Schwartz studied the connection between the immune system and the brain?
Michal Schwartz, an Israeli neuroimmunologist, has conducted groundbreaking research on the relationship between the brain and the immune system. Her work challenged the established belief that the brain was immune-privileged and that immunity should be suppressed in chronic neurodegenerative diseases.
Schwartz discovered that immune system components like macrophages and T cells are essential for spinal cord repair. She developed the concept of protective autoimmunity, where adaptive immune cells support brain function and help repair damaged neural tissue, maintaining brain plasticity. Later, Schwartz explored immunotherapies, such as PD-1 blockers, to treat neurodegenerative diseases like Alzheimer's. Her research has demonstrated the immune response's critical role in repairing the brain, opening new therapeutic avenues.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What discoveries did Michal Schwartz make about immune cells and brain diseases like Alzheimer’s?
Michal Schwartz, an Israeli neuroimmunologist, is known for her groundbreaking research that challenged the idea of brain immunity. She introduced the concept that the immune system can help the brain, rather than harm it.
Schwartz discovered that immune components like macrophages and T cells are essential for spinal cord repair. She developed the concept of protective autoimmunity, where adaptive immune cells support brain function and repair damaged neural tissue, maintaining brain plasticity. Her later work explored immunotherapies, such as PD-1 blockers, to treat neurodegenerative diseases like Alzheimer's. In 2016, Schwartz found that these drugs could halt Alzheimer's disease progression and partially reverse cognitive loss by clearing amyloid-beta plaques in mice, suggesting the immune response plays a crucial role in brain repair and creating new therapeutic opportunities for Alzheimer's disease.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How have Michal Schwartz’s findings influenced treatments for brain disorders?
Michal Schwartz, an Israeli neuroimmunologist, has significantly influenced treatments for brain disorders by challenging the idea that immunity should be suppressed in chronic neurodegenerative diseases.
Her research demonstrated that immune cells, such as macrophages and T cells, are essential for spinal cord repair. Schwartz developed the concept of protective autoimmunity, where adaptive immune cells support brain function and help repair damaged neural tissue, maintaining brain plasticity. She also found that immune cells in the brain promote neurogenesis.
Schwartz investigated immunotherapies like PD-1 blockers for treating neurodegenerative diseases. Her work showed that these drugs could halt Alzheimer's disease progression and partially reverse cognitive loss in mice by clearing amyloid-beta plaques. These findings highlight the immune system's role in brain repair and offer new therapeutic possibilities for Alzheimer's disease.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
Michal Schwartz (born January 1, 1950, Tel Aviv, Israel) is an Israeli neuroimmunologist who carried out pioneering research on the relationship between the brain and the immune system. Her groundbreaking research on Alzheimer disease helped to overturn the long-standing notion that immunity should be suppressed in chronic neurodegenerative disease.
Schwartz earned a bachelor’s degree in chemistry (1972) from the Hebrew University of Jerusalem and a doctorate in immunology (1977) from the Weizmann Institute of Science in Rehovot, Israel. In 1980, following a postdoctoral fellowship at the University of Michigan, where she studied nerve regeneration, Schwartz returned to the Weizmann Institute, becoming a senior scientist in the department of neurobiology and, in 1998, a full professor. In 2016 she held the Maurice and Ilse Katz Professorial Chair in Neuroimmunology.
At the Weizmann Institute, Schwartz focused her studies on the intersection of immunology and neuroscience. In the 1980s, when she began her investigations, it was widely thought that immune cells were prevented from entering the brain by the blood-brain barrier, causing the brain to be “immune privileged,” or free from harmful effects produced by infiltrating immune cells, including inflammation. Hence, immune suppression was considered critical to the successful treatment of brain diseases and disorders. Schwartz, however, was skeptical that the brain operated independently of the immune system. In the early 1990s, she pioneered a new area of brain immunity research by introducing the idea that the immune system helps the brain and the mind.
She discovered that components of the immune system known as macrophages and T cells are required for spinal cord repair. She subsequently developed the concept of protective autoimmunity, in which adaptive immune cells, including CD4+ T cells involved in the recognition of self-antigens (autoimmunity), supported brain function, helped to repair damaged or diseased neural tissue, and thereby played a critical role in maintaining brain plasticity. Schwartz further found that immune cells in the brain support neurogenesis (the growth of new neurons), and she identified the site and underlying mechanism through which beneficial immune cells were recruited to injured spinal cord tissue to facilitate neuronal repair.
In later work Schwartz investigated the possibility of immunotherapies such as PD-1 blockers, a type of cancer immunotherapy, to treat neurodegenerative diseases. In 2016 she and colleagues showed that the drugs were able to arrest Alzheimer disease pathology and partially reverse the cognitive loss associated with disease, evidenced by the clearance of amyloid-beta plaques—sticky protein aggregates that impair brain function and contribute to the progressive degeneration of memory and cognitive abilities in Alzheimer disease—from the brains of affected mice. The findings indicated that the immune response plays a critical role in repairing the brain and created new therapeutic opportunities in Alzheimer disease. That same year, Schwartz identified a link between certain neurodevelopmental disorders and disruptions in the maternal immune system during pregnancy, wherein the timing of immune disruption had a critical influence on fetal brain development.
Schwartz was recognized with numerous honours throughout her career, including the ARVO (Association for Research in Vision and Ophthalmology, Inc.) Friedenwald Award (2002) and the Blumberg Outstanding Medical Research Scientist Prize (2015). In 2014 she was elected president of the International Society of Neuroimmunology and was made an honorary member of the World Immunopathology Organization.